Atticus Wealth Management, LLC Laboratory Corp Of America Holdings Transaction History

Atticus Wealth Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 17, 2024	SELL	$209.01 - $232.56 $209 - $232	-1 Reduced 0.36%	277 $60,000
Q1 2023 Apr 17, 2023	SELL	$213.32 - $257.83 $9,812 - $11,860	-46 Reduced 14.2%	278 $63,000
Q4 2022 Jan 31, 2023	SELL	$203.72 - $248.97 $814 - $995	-4 Reduced 1.22%	324 $76,000
Q2 2022 Jul 13, 2022	BUY	$213.86 - $277.87 $59,025 - $76,692	276 Added 530.77%	328 $77,000
Q1 2022 Apr 15, 2022	BUY	$259.82 - $298.18 $1,039 - $1,192	4 Added 8.33%	52 $14,000
Q3 2021 Oct 18, 2021	SELL	$274.82 - $308.34 $116,798 - $131,044	-425 Reduced 89.85%	48 $14,000
Q1 2021 Apr 15, 2021	SELL	$204.88 - $255.03 $1,229 - $1,530	-6 Reduced 1.25%	473 $121,000
Q4 2020 Jan 20, 2021	BUY	$186.91 - $214.42 $89,529 - $102,707	479 New	479 $98,000

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $20.7B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Atticus Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Atticus Wealth Management, LLC with notifications on news.